Archives rnai

Entry Author Date Location
Avila Gets Leukemia & Lymphoma Society Funding, Dicerna Unites with Ipsen, Rhythmia to Test Heart Mapping Technology, Amag Licenses to Takeda, & More Boston-Area Life Sciences News 04/02/10 Boston
MDRNA and Cequent Pharma in $46M Merger Deal 04/01/10 Seattle
Novell Turns Down Buyout Offer, Alnylam Pulls In $20M from Takeda, $16M Stock Deal Goes to RXi, & More Boston-Area Deals News 03/24/10 Boston
The Decade’s Most Important Biomedical Discovery 12/18/09 Boston
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday 12/09/09 San Diego
Mersana Therapeutics Advancing Anti-Tumor Treatment with Novel Drug-Delivery Technology 12/08/09 Boston
Alnylam Eyes RNAi for Manufacturing Drugs 11/12/09 Boston
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum 10/07/09 Boston
Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body 08/06/09 Boston
Replacing Phil Sharp Will Be Up to Biogen’s Board 07/20/09 Boston
Novartis Extends Alnylam Deal 07/17/09 Boston
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers 04/29/09 San Diego
Cleaner Water Through Biotech? 349Q Kills Water-Borne Microbes with RNAi 04/27/09 Boston
Alnylam to Receive European Patent 04/20/09 Boston
Traversa Gets $5M 04/02/09 San Diego
Intellectual Ventures Inks India Deal, Ontela Teams with T-Mobile, MDRNA Nabs $7.25M, & More Seattle-Area Deals News 03/24/09 Seattle
Aura Biosciences Aims to Develop “Ballistic Missile” Drug to Beat Pancreatic Cancer, Deliver RNAi Therapies 03/12/09 Boston
Regulus Therapeutics Follows Through on Fundraising, Independence Plans 03/04/09 San Diego
RXi to Sell up to $25M in Stock 02/05/09 Boston
Alnylam, Cubist Will Cooperate on RNAi Drug for Lung Infections 01/09/09 Boston
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes 12/18/08 Boston
Mass Life Sciences Center Attracts J&J Matching Funds, Awards $3.7M in Industry-Academic Grants 12/16/08 Boston
Alnylam Forms UCSF Collaboration 12/11/08 Boston
Alnylam Buys More RNAi Patents From Nucleonics 12/08/08 Boston
Aileron Develops New Class of Drugs To Go Where None Could Before 11/07/08 Boston
Alnylam Hires Chief Scientist, Jack Schmidt, To Help Build RNAi Pipeline 10/01/08 Boston
Alnylam Sees Opportunity in Turning Genes On, And Off 09/05/08 Boston
Hub’s Slice of J&J’s R&D Investment Pie—New Funds from the Medical-Products Giant for Harvard and CIMIT 08/18/08 Boston
Alnylam, Novartis Extend RNA Interference Collaboration 07/16/08 Boston
Alnylam Loses RNAi Patent in Europe; Analyst Says No Worries 07/11/08 Boston
Page 3 of 4 « previous page · next page »